Janssen vaccine effective against Delta variant, Johnson & Johnson says

RIO DE JANEIRO, BRAZIL – The pharmaceutical manufacturer said on Thursday, July 1, that its vaccine led to the production of antibodies that lasted at least 8 months against all variants, including the Delta, first detected in India and which has spread worldwide, raising concern in many countries.

The Indian variant is expected to become the dominant strain in the United States in coming weeks, according to the Centers for Disease Control and Prevention (CDCs).

J&J’s vaccine reputedly offers less protection than Pfizer’s and Moderna’s messenger RNA vaccines, and experts are now discussing whether booster doses of the immunizer will be required to prolong protection.

Source: Valor

Related coverage: Brazil's Bolsonaro mocks pressures from left and right for his impeachment · Bolsonaro says pandemic emergency aid can be extended for 2 or 3 months after August · 2020 saw Brazil's lowest investment in infrastructure since 2000 – report · Covid-19: Brazil's rolling average of deaths down for 12th consecutive day

More: Brazil news in English, every day from The Rio Times.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error · Editorial responsibility: Matthias Camenzind, Editor-in-Chief

Brazil runoff, Sunday, October 25: Brazil runoff start time and results schedule. Latest: Brazil runoff polls, Flávio 51%, Lula 49%.